908 Devices (MASS) Net Income towards Common Stockholders (QoQ) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | 908 Devices | 314.43 Mn | 202.69 Mn | 6.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5,760.29% |
| Dec 31, 2025 | 98.64% |
| Sep 30, 2025 | -12.60% |
| Jun 30, 2025 | -130.52% |
| Mar 31, 2025 | 1,374.20% |
| Dec 31, 2024 | 88.32% |
| Sep 30, 2024 | -133.46% |
| Jun 30, 2024 | -14.94% |
| Mar 31, 2024 | -46.95% |
| Dec 31, 2023 | -4.74% |
| Sep 30, 2023 | 24.11% |
| Jun 30, 2023 | 25.42% |
| Mar 31, 2023 | -28.00% |
| Dec 31, 2022 | -56.43% |
| Sep 30, 2022 | 22.72% |
| Jun 30, 2022 | 13.56% |
| Mar 31, 2022 | -170.42% |
| Dec 31, 2021 | 33.17% |
| Sep 30, 2021 | 30.81% |
| Jun 30, 2021 | -22.95% |
| Mar 31, 2021 | 40.49% |
| Dec 31, 2020 | -487.61% |
| Sep 30, 2020 | -193.76% |
| Jun 30, 2020 | 162.05% |